| 1 |
29957545 | Dolutegravir (DTG)-containing regimens after receiving raltegravir (RAL) or elvitegravir (EVG): Durability and virological response in a large Italian HIV drug resistance network (ARCA). | 2018 Aug |
2 |
| 2 |
25924475 | [The in vitro HAART pharmacodynamics study with dolutegravir as the "anchor"]. | 2015 Jan |
1 |
| 3 |
25397500 | Use of dolutegravir in two INI-experienced patients with multiclass resistance resulted in excellent virological and immunological responses. | 2014 |
1 |
| 4 |
21381981 | S/GSK1349572, a new integrase inhibitor for the treatment of HIV: promises and challenges. | 2011 Apr |
2 |
| 5 |
22101373 | Implications of integrase inhibitors for HIV-infected transplantation recipients: raltegravir and dolutegravir (S/GSK 1349572). | 2011 |
2 |